|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/57 | |
| A61P 11/06 | |||
| A61K 45/06 | |||
| A61K 9/10 | |||
| A61K 9/00 |
| (11) | Patento numeris | 1749531 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05016875.6 |
| Europos patento paraiškos padavimo data | 2005-08-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-02-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (72) |
Anker, Stefan, DE
Springer, Jochen, DE
|
| (73) |
Par Pharmaceuticals, Inc.,
300 Tice Boulevard, Woodcliff Lake, NJ 07677,
US
|
| (54) | Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma |
| Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma |